Oral anticoagulation after intracranial haemorrhage: A survey of UK stroke physicians

S. Bell, M. Randall, Al-Shahi R. Salman, Y. Abousleiman, N. Ahmad, A. Ahmed, P. Anderton, S. Andole, T. Anjum, S. Ankolekar, Iqbal Anwar, J. Archer, J. Baker, M. Barber, R. Bathula, M. Bhargava, B. Bhaskaran, T. Black, F. Brodie, D. BroughtonA. Byrne, M. Carpenter, N. Chapman, K. Chatterjee, B. K. Cheripelli, J. Choulerton, B. Clarke, D. Cohen, M. Cooper, L. Coward, P. Crawford, [No Value] Cvoro, B. Dallol, R. Davey, S. Davies, R. Davies, M. Dennis, M. Dhakal, A. Doney, F. Doubal, D. Dutta, K. Dynan, S. Elyas, H. Emsley, T. England, D. Epstein, E. Epstein, S. Evans, P. Findlay, K. Fotherby, J. Furnace, N. Gadapa, T. Garcia, M. Garside, S. Haider, K. Harkness, F. Harrington, A. Hassan, J. Hewitt, M. Hussain, S. Ispoglou, E. Iveson, M. James, D. Jarrett, C. Jenkins, R. Jha, P. Jones, M. Jones, L. Kalathil, A. Kar, A. Kenton, M. Kini, M. Krishnan, K. Krishnan, M. Krommyda, P. Langhorne, R. Licenik, R. Luder, A. Macaden, B. MacInnes, M. MacLeod, J. Marigold, S. Markova, C. McAlpine, M. McCarron, M. McCormick, J. Mcllmoyle, F. McVerry, G. Mead, A. Mistri, Mohd A. Nor, F. Moreton, P. Mudd, M. Myint, M. Naeem, A. Nair, R. OBrien, J. OConnell, P. OMahony, K. Pasco, H. Proeschel, M. Punter, J. Putterill, S. Ragab, S. Raghunathan, C. Rajkumar, H. Ramadan, R. Rayessa, B. Richard, T. Rudd, K. Saastamoinen, M. Sajid, G. Sangster, N. Sattar, U. Schulz, L. Sekaran, S. Sethuraman, S. Shah, K. Sharobeem, L. Shaw, P. Siddegowda, A. Siddiqui, A. Singh, D. Sinha, N. Smyth, N. Sprigg, D. Strain, S. Subramonian, S. Sultan, P. Sutton, J. Sword, P. Talelli, J. Tandy, D. Tryambake, K. Ullah, E. Vasileiadis, M. Wani, T. Webb, T. Webster, N. Weir, D. Werring, W. Whiteley, R. Whiting, S. Whittingham-Jones, P. Willcoxson, D. Wilson, D. Wilson, F. Wright, G. Zacharaiah, T. Zahoor

Research output: Contribution to journalAbstract

14 Citations (Scopus)

Abstract

Introduction: Observational studies suggest that starting oral anticoagulation (OAC) after intracranial haemorrhage (ICH) is beneficial, but a randomised controlled trial (RCT) is needed to confirm this. We assessed opinion about this treatment uncertainty amongst stroke physicians in the UK.

Method: In May 2015, we used Survey Monkey to email an online questionnaire to 289 doctors on the delegation logs at 111 hospital sites participating in the REstart or STop Antithrombotics Randomised Trial (www.RESTARTtrial.org; ISRCTN71907627), followed by 3 email reminders to non-responders.
Original languageEnglish
Pages (from-to)28-29
Number of pages2
JournalInternational Journal of Stroke
Volume10
Issue numberS5
Early online date23 Oct 2015
DOIs
Publication statusPublished - 1 Dec 2015

Keywords

  • Oral anticoagulation
  • Intracranial haemorrhage
  • Stroke physicians
  • UK

Cite this

Bell, S., Randall, M., Salman, A-S. R., Abousleiman, Y., Ahmad, N., Ahmed, A., Anderton, P., Andole, S., Anjum, T., Ankolekar, S., Anwar, I., Archer, J., Baker, J., Barber, M., Bathula, R., Bhargava, M., Bhaskaran, B., Black, T., Brodie, F., ... Zahoor, T. (2015). Oral anticoagulation after intracranial haemorrhage: A survey of UK stroke physicians. International Journal of Stroke, 10(S5), 28-29. https://doi.org/10.1111/ijs.12634_8